GATEKEEPER INNOVATION Trademark

Trademark Overview


On Monday, April 8, 2024, a trademark application was filed for GATEKEEPER INNOVATION with the United States Patent and Trademark Office. The USPTO has given the GATEKEEPER INNOVATION trademark a serial number of 98488310. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, May 8, 2025. This trademark is owned by Hercules Pharmaceuticals, Inc.. The GATEKEEPER INNOVATION trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Business risk assessment services for the pharmaceutical industry in the field of drug diversion risk assessment.

Regulatory compliance consulting for the pharmaceutical industry in the field of drug diversion risk assessment; Regulatory compliance consulting for the pharmaceutical industry in the field of drug supply chain security law interoperability; Regulatory compliance consulting for healthcare providers and participants in the pharmaceutical supply chain.

Providing quality assurance services in the field of pharmaceuticals, including drug diversion risk assessment programs, DSCSA interoperability technology, and regulatory compliance solutions for healthcare providers and participants in the pharmaceutical supply chain.
gatekeeper innovation

General Information


Serial Number98488310
Word MarkGATEKEEPER INNOVATION
Filing DateMonday, April 8, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, May 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBusiness risk assessment services for the pharmaceutical industry in the field of drug diversion risk assessment.
Goods and ServicesRegulatory compliance consulting for the pharmaceutical industry in the field of drug diversion risk assessment; Regulatory compliance consulting for the pharmaceutical industry in the field of drug supply chain security law interoperability; Regulatory compliance consulting for healthcare providers and participants in the pharmaceutical supply chain.
Goods and ServicesProviding quality assurance services in the field of pharmaceuticals, including drug diversion risk assessment programs, DSCSA interoperability technology, and regulatory compliance solutions for healthcare providers and participants in the pharmaceutical supply chain.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, April 11, 2025
Primary Code035
First Use Anywhere DateMonday, November 6, 2023
First Use In Commerce DateMonday, November 6, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 8, 2024
Primary Code042
First Use Anywhere DateMonday, November 6, 2023
First Use In Commerce DateMonday, November 6, 2023

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 11, 2025
Primary Code045
First Use Anywhere DateMonday, November 6, 2023
First Use In Commerce DateMonday, November 6, 2023

Trademark Owner History


Party NameHercules Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPort Washington, NY 11050

Trademark Events


Event DateEvent Description
Monday, April 8, 2024NEW APPLICATION ENTERED
Sunday, September 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 21, 2024ASSIGNED TO EXAMINER
Monday, October 28, 2024NON-FINAL ACTION E-MAILED
Monday, October 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, April 11, 2025TEAS PETITION TO REVIVE RECEIVED
Friday, April 11, 2025NOTICE OF REVIVAL - E-MAILED
Friday, April 11, 2025PETITION TO REVIVE-GRANTED
Friday, April 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 8, 2025NON-FINAL ACTION E-MAILED
Thursday, May 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 8, 2025NON-FINAL ACTION WRITTEN
Monday, October 28, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 18, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND